ALDH7A1 and age-related macular degeneration: Given the lack of current evidence for benefit and known cardiovascular and ocular risks of sildenafil such as non-arteritic ischemic optic neuropathy46, the use of PDE inhibitors as a therapy for AMD should await further evaluation.